Journey Medical Corp (DERM) — Cash Flow Reinvestment Rate
Journey Medical Corp (DERM) has a Cash Flow Reinvestment Rate of 6.74x as of December 2024, reinvesting $15.00 Million (capex $0.00 plus investments $-15.00 Million) from operating cash flow of $2.23 Million. Explore DERM capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Journey Medical Corp Cash Flow Reinvestment Rate (2019–2023)
Historical reinvestment intensity for Journey Medical Corp across 3 annual periods. Also explore Journey Medical Corp (DERM) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Journey Medical Corp (2019–2023)
Year-by-year capital reinvestment analysis for Journey Medical Corp. For live market cap and broader valuation context, see DERM market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.91x | $10.00 Million | $5.24 Million | $5.00 Million | ▲ +308.1% |
| 2020 | 0.47x | $2.40 Million | $5.13 Million | $1.20 Million | ▼ -12.1% |
| 2019 | 0.53x | $4.80 Million | $9.02 Million | $2.40 Million | — |